Why Energy Efficiency Is Critical in Europe’s Data Center Expansion

 

Innovation and Sustainability in Data Center Power Systems

The Europe Data-Center Power Supply Solutions Market is evolving rapidly as organizations prioritize both performance and sustainability. With the exponential growth of digital services, data centers are becoming more energy-intensive, necessitating advanced power management solutions.

A significant trend shaping the market is the adoption of modular power systems. These systems offer scalability and flexibility, allowing operators to expand capacity as demand grows. This approach not only reduces initial investment costs but also improves operational efficiency.

Sustainability is another critical factor influencing market dynamics. Data center operators are increasingly turning to renewable energy sources and energy-efficient technologies to minimize their environmental impact. This shift is driven by both regulatory requirements and corporate sustainability goals.

According to the Europe Data-Center Power Supply Solutions Market Analysis, there is a growing emphasis on integrating smart technologies into power systems. These technologies enable real-time monitoring and optimization of energy usage, enhancing overall efficiency.

The market is also witnessing increased investment in energy storage solutions. Batteries and other storage technologies are being used to ensure uninterrupted power supply and support renewable energy integration. This development is particularly important in regions with fluctuating energy availability.

Another important aspect is the rise of hyperscale data centers. These facilities require high-capacity power solutions to support large-scale operations. As a result, there is a growing demand for advanced power distribution systems and backup solutions.

Edge computing is further influencing the market by driving the need for decentralized power solutions. Smaller data centers located closer to end users require compact and efficient power systems, creating new growth opportunities.

Additionally, advancements in digital technologies are enabling better energy management. Automation and analytics tools are helping operators optimize power usage and reduce operational costs.

In summary, the Europe Data-Center Power Supply Solutions Market is characterized by innovation, sustainability, and rapid growth. As digital demand continues to rise, the adoption of advanced power solutions will be essential in ensuring reliable and efficient data center operations.

What Innovations Are Reshaping Europe Solar PV Landscape?

Europe Solar PV Energy Market continues to expand as renewable energy becomes a cornerstone of the region’s sustainability strategy. The shift toward solar power is driven by stringent environmental regulations, increasing energy demand, and the urgent need to reduce dependence on fossil fuels. As a result, solar photovoltaic systems are gaining widespread adoption across various sectors.

The market is characterized by a diverse range of applications, including residential rooftops, commercial installations, and large-scale solar farms. Each segment contributes uniquely to the overall growth of the industry. Residential users are motivated by cost savings and energy independence, while commercial entities focus on sustainability and operational efficiency.

Insights from the Europe Solar PV Energy Market Analysis highlight the importance of technological innovation in driving market growth. Advancements in solar panel efficiency, inverter technology, and energy storage solutions are enhancing the performance and reliability of solar systems. These innovations are making solar energy more competitive with traditional power sources.

Government policies play a crucial role in shaping the market. Incentives such as tax credits, subsidies, and feed-in tariffs encourage investment in solar projects. Additionally, regulatory frameworks are being streamlined to facilitate faster project approvals and reduce administrative barriers. These measures are creating a favorable environment for market expansion.

Energy storage integration is becoming increasingly important as solar adoption grows. Battery systems enable the storage of excess energy generated during peak sunlight hours, ensuring a consistent power supply even during periods of low generation. This capability is essential for maintaining grid stability and maximizing the benefits of solar energy.

The corporate sector is actively contributing to the growth of the Europe Solar PV Energy Market. Companies are investing in renewable energy to meet sustainability goals and reduce operational costs. Power purchase agreements are enabling businesses to secure long-term access to clean energy, driving demand for solar installations.

Despite the positive outlook, the market faces challenges such as grid congestion and land availability constraints. In some regions, the existing infrastructure is not sufficient to support large-scale solar integration. Addressing these issues requires significant investment in grid modernization and efficient land use planning.

The competitive landscape is evolving rapidly, with both established players and new entrants vying for market share. This competition is fostering innovation and driving down costs, benefiting consumers and accelerating market growth. Companies are focusing on expanding their portfolios and leveraging advanced technologies to stay ahead.

Looking ahead, the Europe Solar PV Energy Market is expected to experience sustained growth. The combination of policy support, technological advancements, and increasing demand for clean energy will continue to drive the market forward. Solar PV will play a critical role in achieving Europe’s long-term energy and climate objectives.

Future Growth Prospects for Dehydrated Fruits & Vegetables

 

The dehydrated fruits and vegetables industry operates within a competitive environment shaped by product quality, processing technology, and distribution reach. Market participants range from large multinational food processors to specialized regional producers. Understanding competitive positioning provides clarity on how companies capture and sustain market presence.

Product differentiation is a primary competitive factor. Companies invest in advanced dehydration techniques to preserve color, texture, and nutritional value. Freeze-drying, in particular, is often associated with premium offerings due to superior quality retention. Brands that successfully communicate these advantages strengthen their competitive positioning among quality-conscious buyers.

Sourcing strategies also influence competition. Access to high-quality raw produce ensures consistent output and cost control. Producers with strong relationships with farmers or vertically integrated operations often gain supply stability, which supports reliable fulfillment and long-term contracts with food manufacturers.

Within the broader Dehydrated fruits & vegetables market, distribution networks play a critical role in shaping competition. Companies with established global logistics capabilities can serve diverse markets efficiently. This reach enhances brand visibility and enables participation in international trade.

Assessment of Dehydrated Fruits & Vegetables Market Share highlights how leading players maintain dominance through scale, innovation, and portfolio diversity. Larger companies benefit from economies of scale, while smaller firms often focus on niche segments such as organic or specialty products.

Pricing strategies further define competitive dynamics. Bulk industrial suppliers emphasize cost efficiency and long-term supply agreements, whereas consumer-focused brands prioritize value-added packaging and branding. This segmentation allows multiple competitors to coexist while serving different demand profiles.

Regional competition varies based on processing capacity and consumption patterns. North America and Europe emphasize quality standards and certifications, while Asia-Pacific regions focus on volume production and export potential. Companies adapt competitive strategies accordingly to align with regional market expectations.

Innovation remains a key differentiator. Investment in process optimization, energy efficiency, and sustainable packaging strengthens brand positioning. These initiatives not only reduce costs but also appeal to environmentally conscious buyers and institutional customers.

Overall, competitive positioning in the dehydrated produce industry depends on balancing quality, efficiency, and market reach. As demand continues to expand across applications, companies that align operational strengths with evolving customer needs are likely to retain or grow their market share in a dynamic global environment.

Browse More Report:

Extra Virgin Olive Oil Market
Virgin Coconut Oil Market
Organic Food Preservatives Market
Organic Cocoa Market
Flavour Market

Global Hair Removal Devices Market to Witness Increasing Revenue Growth during the Forecast Period 2017-2023

 Hair Removal Devices Market Overview: 

The global report on the hair removal devices market reveals that the market is expected to take a leap from its previous valuation of USD 915.2 million in 2017 with a 8.8% CAGR during the forecast period of 2018 to 2023. Market Research Future (MRFR) considers several factors like fashion, sports, cultural practices, military, medical reasons, and others as prominent growth-inducing avenues for the market. The easy availability of these products through retail and e-commerce lines strongly denotes hair removal devices market trends and better awareness regarding the product can boost the market prospect. 

Hair Removal Devices Market Segmentation: 

MRFR’s analysis of the global hair removal devices market leads to an in-depth segmentation of product and end-user. These segments have multiple inputs from various factors that help in gaining insights and developing better marketing strategies. 

By products, the global market for hair removal devices can be segmented into laser devices, intense pulse light (IPL) devices, energy-based devices, and others. The laser devices segment includes Nd: YAG laser, diode laser, and alexandrite laser. The laser devices segment had the maximum market share in 2017 and it is getting more traction from wider acceptance of the devices. The product is also performing better than other devices. 

By end-users, the global report on the hair removal devices market comprises beauty clinics, home use, dermatology clinics, and others. The beauty clinics segment had the largest market share in 2017 owing to its huge women customer base. 

Hair Removal Devices Market Regional Analysis: 

The Americas is expected to make huge profit in the coming years in the hair removal devices market. This is primarily due to the high investment capacity, better disposable income standards, increasing launch of innovative products, and others. The US and Canada are performing better. In Europe, this growth would be backed by the growing sale in France, Germany, Italy, Spain, and the UK. In Asia Pacific, China, India, Japan, and South Korea are expected to boost the market traction.  

Hair Removal Devices Market Competitive Landscape: 

The global hair removal devices market growth can benefit substantially from various companies like Sciton, Inc, Alma Lasers, Ltd., Syneron Medical Ltd., Cutera Inc., Cynosure, Inc., Lynton Lasers Ltd, Solta Medical Inc., Strata Skin Sciences, Inc., Lumenis Ltd, Lutronic Corporation, and Venus Concept Canada Corp. These companies have done research works and have set their own growth policies to establish a strong outcome for themselves. The global market is slated to benefit from their mergers, acquisitions, collaborations, hike in research activities, better investment in research and development projects, and others are expected to steer the market towards innovations. MRFR recorded these recent moves to get their hands on various prospects in the coming days. 

Browse Full Report with TOC at: https://www.marketresearchfuture.com/reports/hair-removal-devices-market-7323

Hair Removal Devices Industry News: 

In April 2020, Aldi Australia announced that they would launch a new DIY or do-it-yourself hair removal gadget that promises salon-like experience. The product will be priced around USD90. It is supposed to hit the market in May. The company is trying to get hold of the market as the Australian government has banned all the beauty salons from functioning for the time being. 

On the other hand, IPL hair removal devices are losing grounds due to the COVID-19 pandemic outbreak. This is due to the lack in intake of the product that is happening all around the world. With lockdowns in motion, getting hair removal done from clinics and salons are now out of question, which led to a financial crisis. This crisis is impacting the intake.

Hematology Diagnostics Market Analysis 2017-2023 by Share, With Impact Analysis of COVID-19, Leading Key Players, Future Growth, Revenue, Demand Forecast

 Hematology Diagnostics Market Synopsis

Market Research Future (MRFR) speculates that the global hematology diagnostics market is predicted to demonstrate a robust CAGR during the forecast period (2018–2023) owing to the augmenting prevalence of blood disorders. Hematology is referred to as the branch of science which deals with the prognosis, cause, treatment, and prevention of blood disorders. Hematology diagnosis comprises the calculation of WBC, RBC, and platelets. It consists of the problems associated with RBC, WBC, lymph, bone marrow, and platelets. It comprises IVD technologies like flow cytometry, blood analysis, molecular diagnostics, immunodiagnostics, histology, hemostasis, and cytology.

Hematology Diagnostics Market Potential and Pitfalls

The augmenting prevalence of blood disorders coupled with technological advancements is considered to contribute to the hematology diagnostics market growth. Factors influencing the hematology diagnostics market are the rising incidences of genetic diseases, high adoption of hematology analyzers, increasing blood transfusions and donations, and rising hematological testing. As per the CDC and Prevention, around 70,000 to 100,000 of the Americans suffered from sickle cell disease in 2017, which is considered as a genetic blood disorder.

Automation is considered as one of the major areas of focus for hematology labs. Laboratories are extensively adopting automation for analytical, post-analytical, and pre-analytical steps in order to improve efficiency and also standardize the process. Processes such as processing, automation sample collection, test ordering, and test identification minimize the administrative errors besides facilitating reliable test results. Such factors are anticipated to contribute to the market growth to a large extent. Moreover, the increasing adoption of point-of-care (POC) hematology tests is presumed to influence the markeat growth as these tests are user-friendly and reduces the need for user-training.

On the contrary, poor healthcare insurance coverage for diagnosis, the high cost of diagnosis, and lack of awareness are some of the major concerns anticipated to slow down the market growth throughout the appraisal period.

Global Hematology Diagnostics Market: Segmental Analysis

The global hematology diagnostics market has been segmented on the basis of tests, product type, and end-user.

By mode of product type, the global hematology diagnostics market has been segmented into flow cytometers, hematology analyzers, and consumables. Among these, the hematology consumables segment is predicted to lead the global market owing to the increasing awareness of blood disorders among the patients and the healthcare professionals. Moreover, with the rising test volume due to the increasing awareness and early detection, the segment is considered to flourish.

By mode of tests, the global hematology diagnostics market has been segmented into hemoglobinopathy, anemia, hematology pathophysiology, leukemia/lymphoma phenotyping, complete blood count (CBC), and others.

By mode of end-users, the global hematology diagnostics market has been segmented into ambulatory surgical centers, hospitals and clinics, academic institutes, diagnostic laboratories, and others. Among these, the hospital's segment is considered to dominate the global market. Diagnostic laboratories are predicted to expand at a rapid pace owing to the rising number of diagnostic centers coupled with the availability of advanced instruments.

Hematology Diagnostics Market Regional Insights

Geographically, the hematology diagnostics market span across regions namely, Europe, America, Asia-Pacific, and the Middle East and Africa.

Among all the regions, the North American region is predicted to dominate the global hematology diagnostics market and is likely to retain its dominance in the coming years. The growth is credited to the increasing prevalence of blood diseases in this region. As per Statista, 33% of all the Americans were diagnosed with hemophilia A in 2016. Factors contributing to the market growth are the presence of market giants like Bio-Rad Laboratories, Abbott Laboratories Danaher, and others coupled with the technological advancements and rising healthcare expenditure in this region.

The European region is predicted to occupy the second largest position in the global market owing to the rising hematology research in this region. For instance, the 16^th World Hematology Congress will be conducted in London, in March 2019 in order to discuss the blood disorders, treatment, and diagnosis of hematology, hematologic disorders, hematologic oncology, and immunohematology.

The Asia Pacific region is anticipated to expand at the fastest rate due to the increasing prevalence of genetic diseases and blood disorders in this region.

Browse Full Report with TOC at: https://www.marketresearchfuture.com/reports/hematology-diagnostics-market-6262

Hematology Diagnostics Industry Updates

February 14, 2019: The ERBA Group, a leading global In-vitro diagnostic company, at their recently concluded MEDLAB expo, launched their latest hematology analyzers H 560 and H 360. They have been designed to improve the efficiency of the lab. With the emergence of these systems, better healthcare outcomes are penetrating the global market.

Hematology Diagnostics Market Competitive Dashboard

The prominent players operating the global hematology diagnostics market are BioSystems (Spain), Ortho Clinical Diagnostics (US), Abbott Laboratories (US), EKF Diagnostics (UK), Diatron (Hungary), Sysmex (Japan), Roche (Switzerland), Siemens (Germany), Boule Diagnostics (Sweden), Danaher (US), Mindray (China), Bio-Rad Laboratories (US), Drew Scientific (US), Nihon Kohden (Japan), HORIBA (Japan), and others.

RSV Diagnostics Market 2021, Revenue Growth, Development And Demand Forecast

 RSV Diagnostics Market Highlights

The latest report by Market Research Future (MRFR) states that the Respiratory Syncytial Virus (RSV) market is all set to gain substantial traction by accruing gigantic revenues by 2023. In addition, it is on track to surge at a CAGR of 10.4 % during the forecast period (2018–2023).

RSV Diagnostics Market Drivers and Top Restraints

The document named “Reducing Neonatal Mortality and Morbidity in Latin America And the Caribbean, An Interagency Strategic Consensus” states that almost 400,000 children under the age of five die due to infections that could have been prevented. This has attracted the focus of various health agencies that are striving to get a hold of the issue. For instance, Latin American Center for Perinatology and Pan America Health Organization (PAHO) have diverted their focus in the direction of educating the parents to fight against possible infections, promoting the growth of the RSV diagnostics market in the process.

The rising incidence rate of respiratory infections has done wonders for the market and is bound to surge at a significant rate in the coming years. with the growth in the incidences of chronic diseases around the world, there is bound to be an increase in the case of respiratory infections. This is going to have a definite positive impact on the demand for testing of infectious diseases like RSV. The deaths among neonates owing to these infections can be prevented when timely diagnosis and subsequent treatment is provided. Thus, the growing awareness regarding this factor is set to enhance the growth of the RSV diagnostics market in the years ahead.

The boost in the number of product launches across the globe will be one of the primary reasons fueling the growth of the respiratory syncytial virus diagnostics market in the forthcoming years. On that note, various diagnostics companies are keen on expanding their revenue with the development and introduction of the latest RSV diagnostics products in the market. These sophisticated diagnostic products are known to be highly efficient and reduce the time needed for the diagnosis.

The Rising Number of OEMs to be the Key Trend in the Global Market

The growth in the number of original equipment manufacturers (OEMs) is on its way to become a popular trend in the worldwide RSV diagnostics market in the near future. OEMs like Thermo Fisher Scientific and Sekisui Diagnostics are one of the leading manufacturers that offer RSV diagnostics.

There has been a rise in the number of combination products like drug delivery and smart devices, which is prompting the OEMs to work in conjunction with the contract manufacturing organizations (CMOs), making way for a number of new companies to gain entry into the market. As a result, there has been an increase in the product range required for diagnosing RSV. 

RSV Diagnostics Market Segmentation

The global RSV diagnostics market has been segmented based on product, method, and end-user.

Depending on the type of product, the market has been classified into kits and assays, instruments, and other products.

Method-wise, the global RSV diagnostics market has been considered for molecular diagnostics, rapid antigen detection test, gel microdroplets, flow cytometry, and others. Furthermore, the rapid antigen detection tests are sub-segmented into enzyme-linked immunosorbent assays, immunofluorescence assays, and other rapid antigen detection tests. The other type of rapid antigen detection tests can be segmented into chromatographic immunoassays and optical immunoassays.

The end-users mentioned in the report include hospitals and clinics, clinical laboratories, home care, and others.

RSV Diagnostics Market Regional Outlook

The global RSV diagnostics market is segmented into the regional markets of the Americas, Asia Pacific, Europe, as well as the Middle East & Africa.

The Americas will be the most lucrative market for RSV diagnostics on account of the rising incidences of RSV, growing healthcare expenditure and technological advancements in molecular diagnostics. As per the Centers for Disease Control and Prevention, over 57,000 children younger than five years old are hospitalized owing to RSV infection every year, in the United States (U.S). In order to bring down this abysmal number, various initiatives and programs are being introduced in the region, which means that the market will be doing excellent business in the region in the years to come.

Meanwhile, Europe has landed the second spot in the global RSV diagnostics market, with factors like increasing automation in vitro diagnostics, rising occurrence of RSV diseases, and surging funding offered by the government backing the said growth. Considering the current status of the region, the data furnished by the University of Oxford states that more than 30,000 babies and children less than five years of age are expected to be hospitalized every year owing to RSV.

The RSV diagnostics market in Asia Pacific can be broken down into smaller markets in the countries of India, Japan, China, Republic of Korea, Australia and the rest of the region. The regional market is touted to be the fastest-growing globally as a result of the rise in the infectious disease which includes the RSV infection. Also, the increasing healthcare expenditure coupled with the surge in the demand for RSV disease diagnosis has taken the market to higher levels in the past few years. In addition, countries like India, China, and Japan are deemed to be growing at the fastest rate in the region with the expanding healthcare systems along with the growing government initiatives backing up these markets.

Showcasing a rather sluggish growth rate in the global market is the region of the Middle East and Africa, which despite various restraints holds immense potential. The market shows promise, with the support of various factors including the increasing awareness and high investments by private industry participants combined with the increasing incidences of RSV in children in the region. 

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @ https://www.marketresearchfuture.com/reports/rsv-diagnostics-market-6217

RSV Diagnostics Market Key Vendors

Bio-Rad Laboratories Inc., Abbott, F. Hoffman-La Roche Ltd., Danaher Corporation, Quest Diagnostics, Biocartis, Luminex, Hologic, Fast Track Diagnostics, Biomerieux, Becton, Dickinson, and Company (BD), Alere, Inc., Quidel Corporation, Thermo Fisher Scientific are among some of the top most companies in the RSV diagnostics market.

RSV Diagnostics Industry Latest News

May 2019: SpeeDx Pty. Ltd. has gotten the clearance from the Australian Therapeutic Goods Administration (TGA) of their PlexPCR RespiVirus test. It makes use of the PlexPCR technology for detecting 11 types of pathogens known for causing viral respiratory-illnesses. In addition, this test also lets the laboratories process a greater number of samples in a limited period of shift compared to a conventional in-house test.

Dry Powder Inhaler Market Will hit at a CAGR of 4% from 2017 to 2026

According to Future Market Insights, the global market for dry powder inhaler is slated to exhibit a CAGR of nearly 4% during the forecast period (2017-2026), in terms of volume. Over 4000,000 Mn units of dry powder inhaler are pegged to be sold across the globe by 2026-end.

Challenges Regarding Varying Characteristics of Dry Powder Inhalers to Pave Opportunities for Medical Device Manufacturers

Regulatory pressures and changes in drug delivery market have driven innovation of the dry powder inhaler forward. According to the World Health Organization (WHO), nearly 300 Mn people worldwide are affected by asthma, and approximately 240 Mn from the chronic obstructive pulmonary disease (COPD). Over half of these patients combined prefer use of dry powder inhalers for treatment of their disease. These devices have depicted great potential in effective and reliable drug delivery, with novel designs ensuring the possibility to overcome future compliance, cost, and safety challenges. 

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-5150

Some of the essential performance characteristics regarding dry powder inhalers are associated with dose-delivery, performances at varying airflows, and fine particle fraction content. These characteristics may vary with respect to powder formulations, creating the need for fine tuning of the device or powder formulation or both combined for achieving optimal performance. The requirement is particularly high in micro-dosing dry powder inhalers, which in turn is paving opportunities for medical device manufacturers in terms of innovations and advancements.

Growing adoption of unhealthy lifestyle, increasing geriatric population, and growing air pollution levels fuelling prevalence of various respiratory disorders are key factors driving expansion of the global dry powder inhaler market. In addition, favorable government initiatives being taken across the globe for improving the healthcare infrastructure will further influence the market growth in the near future. However, the fact that dry powder inhalers are not moisture-resistant remains a major challenge for manufacturers, as the medicine loses its properties when it comes in contact with the moisture. Availability of effective alternatives such as nebulizers and electric pumps are expected to restrain adoption of dry powder inhalers. Lack of awareness regarding these devices in low-income & underdeveloped countries may further hinder the market growth to a certain extent.

Key Research Findings from FMI’s Report on Dry Powder Inhaler Market

• North America will continue to be the most lucrative region for growth of the dry powder inhaler market. Dry powder inhaler sales in the region will register the fastest expansion through 2026. Asia-Pacific excluding Japan (APEJ) is expected to be the second largest market for dry powder inhaler.
• Hospital pharmacies will continue to be the leading distribution channel for dry powder inhalers, with sales pegged to surpass 150,000 Mn units by 2026-end.
• Dry powder inhalers will continue to observe the largest application in the treatment of asthma, followed by chronic obstructive pulmonary disease. In addition, sales of dry powder inhalers for application in the treatment of asthma and pulmonary arterial hypertension are slated to exhibit a parallel growth through 2026.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-5150

Leading companies in the global dry powder inhaler market are focusing on the development of new generation products. These market players are making huge investments in R&D activities associated with novel device architectures, particle engineering, and powder formulations. Development of improved particle properties, along with efficient inhaler designs is expected to remain key strategies among the market players. Key market participants profiled in the report include Vectura Group Plc, MannKind Corporation, Chiesi Farmaceutici S.p.A., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Limited, Cipla Ltd., Novartis AG, GlaxoSmithKline Plc, 3M Company, and Astrazeneca Plc.

Analgesics Market will reach at a CAGR of 5.3% from 2018 to 2028

By drug class, opioids are widely used analgesic drugs for treating moderate to severe pain such as pain caused by surgery, cancer, trauma, injury, and other diseases. Owing to their high efficiency and widespread availability in the developed markets of North America and Western Europe, opioids are a high revenue generating segment in the global analgesics market. In a new research publication, leading market research firm Future Market Insights presents forecasts on revenue generated from the sales of branded and generic analgesic drugs including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and local anaesthetics.

According to Future Market Insights’ projections, the global prescription analgesics market is anticipated to reach a whopping US$ 79 Bn by 2028 end, up from an estimated US$ 47.5 Bn in 2018. This is indicative of a CAGR of 5.3% during the 10 year period from 2018 to 2028. This growth is mainly contributed by the regional markets in North America and Western Europe that are projected to collectively hold a revenue share of just under 71% in 2018.

Commercialization of Abuse Deterrent Opioid Drugs to Provide Lucrative Growth Opportunities to Pharmaceutical Majors in the Analgesics Market

Following the U.S opioid crisis, several countries across the globe are introducing regulations pertaining to the prescription of opioids. To curb the growing abuse of painkilling drugs, pharma companies are introducing different types of abuse deterrent drugs in the global market. Opioids are widely used for pain management in North America and Europe and are being increasingly used for non-medical purposes as well. Government organizations in these economies are encouraging doctors to prescribe non-opioid analgesics. This is slated to create significant growth opportunities for companies to introduce novel non-opioid drugs in these markets. The situation in the countries of Asia and Africa is different – the limited availability of both opioid and non-opioid drug delivery systems for pain management provides immense opportunities to manufacturers of analgesics for regional market penetration.  

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-1306

Opioid intolerance is a new phenomenon that has hit the pharmaceuticals industry in North America and Europe. Opioids are ineffective in treating certain cases of severe pain, necessitating patients to take higher doses to alleviate the pain. This eventually makes them opioid intolerant or addicted to these drugs. Commercializing opioid tolerant drugs is the most viable solution that will help reduce the side effects associated with increasing consumption of opioids. Manufacturers in the global analgesics market are expected to benefit from the numerous opportunities presented by the commercialization of opioid tolerant drugs.

Development of Non-opioid Extended Release Drugs and Commercial Expansion via Novel Product Approvals to Fuel Revenue Growth

Key players in the global analgesics market are focused on R&D initiatives to develop non-opioid drugs using innovative drug delivery approaches to facilitate extended release of the medication, which can provide pain relief for a longer time duration. Pharmaceutical companies are also launching cost-efficient opioid drugs in Asian countries and this is expected to boost revenue growth in the global market for analgesics. Commercial expansion of products across potential growth markets in Asia and Africa is a feasible strategy being adopted by manufacturers of analgesics to expand their global market footprint.

Reimbursement for Palliative Care and Opioid Consumption Trending the Global Market

Opioids are largely used in palliative care for treating terminally ill patients. There is a growing focus on palliative care services across third world countries. This – coupled with readily available reimbursement options – is expected to boost the consumption of opioids in the coming decade. Several government initiatives to promote palliative care among patients suffering from cancer pain in low and middle income countries are promoting the adoption of opioids as an effective pain management solution.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-1306

Another trend being observed in the global market is the use of Opioids Maintenance Treatment (OMT) to treat Opioids Dependence (OD). The main objective of OMT is to reduce patients’ addiction to consume illicit drugs that are used to reduce opioid dependency. While there are certain controversies associated with the commercialization of OMT (it is claimed that OMT is another form of addiction), these drugs are highly regulated and the concerned governments are implementing stringent regulations to prevent abuse of these drugs.

Sports Medicine Market: North America to Lead the Global Market in Terms of Revenue

Sports medicine, an upcoming healthcare field, involves the treatment of various injuries related to sports along with athlete evaluation with a view to improve the athletic performance. Sports sector has witnessed large participation of population in sports. The growth of the sports medicine market can be primarily attributed to the increasing sports injuries. Another aspect that is pushing the growth of the global sports medicine market is the growing technological advancements in the medicine and medical devices sectors that is introducing new products in the market. This has triggered the adoption of sports medicine by consumers on a large scale, thus widening its scope in various application areas. Moreover, influx of new modalities coupled with innovations in the field of regenerative medicine and allografts have contributed to the growth of the global market for sports medicine in recent years. Increasing number of players in the sports medicine, penetration of large players in this field, growing government support and increasing awareness are set to drive the growth of the sports medicine market. However, high prices are associated with sports medicine, especially orthopaedic implants which is challenging the growth of the global market.

The comprehensive research report on “Sports Medicine Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2022)”, skilfully crafted by Future Market Insights reveals various aspects of the global sports medicine market along with key product types and applications, the analysis of which can be used to achieve expansion milestones in the years to come. As per sports medicine market research study, projection is that the market is expected to expand at a robust CAGR of 7.4% throughout the 2017-2022 period of assessment.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-5173

4 Key Highlights on Global Sports Medicine Market

The global sports medicine market has been segmented by product type, by application and by region.

• By application, the knee injury segment reflects high potential with respect to both market share and growth in the years to come. The prevalence of knee injuries is rising among the athlete population. This fact has called for quick and effective treatment of knee injuries, thus making it a more lucrative segment. The knee injury segment by application is anticipated to grow at the robust rate to reflect a market share of 32.3% as of 2017, thus leading the global market and this trend is anticipated to continue over the assessment period
• The shoulder injury application segment is also gaining significant traction since last couple of years. This segment is projected to grow at a 7.4% CAGR during the period of forecast to reach a noteworthy market share by 2022 end. This segment stands second in terms of market value during 2017-2022 followed by ankle and foot injuries application category
• North America is the largest and the most attractive region for the growth of the global sports medicine market pertaining to market share. The sports medicine market in North America region is projected to grow at CAGR more than 7.0% throughout the assessment period. With respect to market share, Europe stands second to North America growing at a high CAGR. Asia-Pacific excluding Japan (APEJ) region is also anticipated to show significant growth in the years to come
• Body Reconstruction segment by product type is expected to lead the global market as it reflects a high market share of more than 40% as of 2017 growing at a robust CAGR throughout the period of forecast. Body support and recovery segment is the second largest segment during the assessment period

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-5173 

Global sports Medicine Market: Competitive Scenario

The research report on global market for sports medicine has profiled several key players involved in sports medicine domain. Their detailed analysis with respect to product portfolio, company overview, recent developments and innovations, SWOT analysis and key financials has been included in this research report. Key players such as Arthrex, Inc., Smith & Nephew Plc., Stryker Corporation, CONMED Corporation, Zimmer Biomet Holdings, Inc., Mueller Sports Medicine, Inc., Wright Medical Group N.V., Medtronic Plc, Johnson & Johnson and Breg Inc., are profiled in this study.